Psoriasis Therapeutics Market to Hit 1.2 Billion USD in Revenues by 2021

1
Psoriasis Therapeutics in Asia- Pacific Markets
to 2021 Advent of Novel Biologics and Expanding
Treatment Pool to Drive Growth
Published on 01 May, 2015 Number of pages
91 Single User Price 4995
In 2014, the value of the psoriasis therapeutics
market in APAC amounted to an estimated 690m,
and it is forecast to grow at a Compound Annual
Growth Rate (CAGR) of 8.4 between 2014 and 2021
to reach 1.2 billion.
2
Summary of the ReportMarketIntelReports
Research, the leading business intelligence
provider, has released its latest research,
"Psoriasis Therapeutics in Asia-Pacific Markets
to 2021 Advent of Novel Biologics and Expanding
Treatment Pool to Drive Growth", which provides
insights into psoriasis therapeutics in the
Asia-Pacific (APAC) market. For the purposes of
this report, APAC refers to the market in China,
India, Japan, and Australia only. The report
estimates the market size for 2014, along with
forecasts until 2021. In 2014, the value of the
Psoriasis Therapeutics Market in APAC amounted to
an estimated 690m, and it is forecast to grow at
a Compound Annual Growth Rate (CAGR) of 8.4
between 2014 and 2021 to reach 1.2 billion. The
psoriasis treatment landscape is a particularly
complex one. More than 80 of patients fall into
the mild-or-moderate category, for which the
first line of treatment is topical drugs,
phototherapy, or a combination. In the case of
severe patients, non-steroidal drugs such as
methotrexate, cyclosporine, and acitretin are
practiced as first-line treatment however, they
come with toxicity concerns and so cannot be
prescribed for long durations.
Click Here To Check Complete Report
3

• Scope of the Report
• The report analyzes treatment use patterns,
  market characterization, the pipeline, and key
  licensing and co-development deals for psoriasis
  in the APAC markets of China, India, Japan, and
  Australia.The report includes -
• A brief introduction to psoriasis, including
  pathophysiology, etiology, diagnosis, and
  treatment algorithms
• In-depth analysis of currently marketed drugs,
  including analysis of safety, efficacy, treatment
  patterns, and strengths/weaknesses, along with a
  heat map comparing them in terms of safety and
  efficacy
• A comprehensive review of the pipeline for
  psoriasis, including individual analysis of a
  number of late-stage pipeline drugs likely to
  enter the market during the forecast period the
  pipeline is further analyzed on the basis of
  phase distribution, molecule type, program type,
  mechanism of action, and molecular target
• Additional in-depth analysis of pipeline drug
  clinical trials by phase, trial size, trial
  duration, and program failure rate for each
  molecule type

Download Sample Brochure
4

• Reasons to buy
• The report will enhance your decision-making
  capability by allowing you to -
• Understand the psoriasis pipeline and the factors
  that indicate that it is becoming more innovative
• Analyze detailed profiles for promising pipeline
  products and gain insights into how they are
  likely to compete in the market and who their
  main competitors will be
• Follow the trends in psoriasis clinical trial
  size and duration in relation to industry
  averages
• Assess the potential risk of future developmental
  programs for psoriasis therapeutics by mechanism
  of action using recorded clinical trial failure
  rates
• Analyze the potential growth patterns expected
  for the psoriasis market over the forecast period
• Identify the countries that are expected to
  contribute the most to this growth and devise a
  more effectively tailored country strategy
  through an understanding of key drivers and
  barriers
• Accelerate and strengthen your market position by
  identifying key companies for strategic
  partnerships

Make an Inquiry Before Buying
5
Psoriasis Therapeutics in Asia- Pacific Markets
to 2021 Advent of Novel Biologics and Expanding
Treatment Pool to Drive Growth
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the Psoriasis Therapeutics Market are provided in
the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Psoriasis
Therapeutics Market Report